Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chel Hun Choi

Showing results (251-260 of 309) with videos related to

Pageof 31
Sort By:
Plos One|January 3, 2025
Correction: Impact of PARP inhibitor maintenance therapy in newly diagnosed advanced epithelial ovarian cancer: A meta-analysisBanghyun Lee, Suk-Joon Chang, Byung Su Kwon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2025
Neoadjuvant Chemotherapy with Dual Immune Checkpoint Inhibitors for Advanced-Stage Ovarian Cancer: Final Analysis of TRU-D Phase II Nonrandomized Clinical TrialJunsik Park, Je-Gun Joung, Myong Cheol Lim, et al.
Gynecologic Oncology|May 17, 2011
Prognostic value of the copper transporters, CTR1 and CTR2, in patients with ovarian carcinoma receiving platinum-based chemotherapyYoo-Young Lee, Chel Hun Choi, In-Gu Do, et al.
Oncotarget|August 28, 2015
Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancerHyun-Soo Kim, Gun Yoon, Ji-Yoon Ryu, et al.
Cancer Research and Treatment|March 8, 2018
Development and Validation of Ovarian Symptom Index-18 and Neurotoxicity-4 for Korean Patients with Ovarian, Fallopian Tube, or Primary Peritoneal CancerMaria Lee, Yumi Lee, Kidong Kim, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 27, 2010
Peritoneal tuberculosis: a retrospective review of 20 cases and comparison with primary peritoneal carcinomaChel Hun Choi, Chul-Jung Kim, Yoo-Young Lee, et al.
Journal of Translational Medicine|June 19, 2017
Synaptonemal complex protein 3 is associated with lymphangiogenesis in non-small cell lung cancer patients with lymph node metastasisHaruhisa Kitano, Joon-Yong Chung, Kyung Hee Noh, et al.
Plos One|November 17, 2023
Impact of PARP inhibitor maintenance therapy in newly diagnosed advanced epithelial ovarian cancer: A meta-analysisBanghyun Lee, Suk-Joon Chang, Byung Su Kwon, et al.
Journal of Gynecologic Oncology|January 5, 2024
Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelinesBanghyun Lee, Suk-Joon Chang, Byung Su Kwon, et al.
Gynecologic Oncology|May 1, 2025
Oncologic outcomes of minimally invasive surgery vs. abdominal hysterectomy in patients with low-risk, early-stage cervical cancer: A retrospective analysis of KGOG 1028 data based on SHAPE trial eligibility criteriaJaekyung Bae, Uisuk Kim, E Sun Paik, et al.
Pageof 31

Showing results (251-260 of 309) with videos related to

Sort By:
Pageof 31
Plos One|January 3, 2025
Correction: Impact of PARP inhibitor maintenance therapy in newly diagnosed advanced epithelial ovarian cancer: A meta-analysisBanghyun Lee, Suk-Joon Chang, Byung Su Kwon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2025
Neoadjuvant Chemotherapy with Dual Immune Checkpoint Inhibitors for Advanced-Stage Ovarian Cancer: Final Analysis of TRU-D Phase II Nonrandomized Clinical TrialJunsik Park, Je-Gun Joung, Myong Cheol Lim, et al.
Gynecologic Oncology|May 17, 2011
Prognostic value of the copper transporters, CTR1 and CTR2, in patients with ovarian carcinoma receiving platinum-based chemotherapyYoo-Young Lee, Chel Hun Choi, In-Gu Do, et al.
Oncotarget|August 28, 2015
Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancerHyun-Soo Kim, Gun Yoon, Ji-Yoon Ryu, et al.
Cancer Research and Treatment|March 8, 2018
Development and Validation of Ovarian Symptom Index-18 and Neurotoxicity-4 for Korean Patients with Ovarian, Fallopian Tube, or Primary Peritoneal CancerMaria Lee, Yumi Lee, Kidong Kim, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 27, 2010
Peritoneal tuberculosis: a retrospective review of 20 cases and comparison with primary peritoneal carcinomaChel Hun Choi, Chul-Jung Kim, Yoo-Young Lee, et al.
Journal of Translational Medicine|June 19, 2017
Synaptonemal complex protein 3 is associated with lymphangiogenesis in non-small cell lung cancer patients with lymph node metastasisHaruhisa Kitano, Joon-Yong Chung, Kyung Hee Noh, et al.
Plos One|November 17, 2023
Impact of PARP inhibitor maintenance therapy in newly diagnosed advanced epithelial ovarian cancer: A meta-analysisBanghyun Lee, Suk-Joon Chang, Byung Su Kwon, et al.
Journal of Gynecologic Oncology|January 5, 2024
Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelinesBanghyun Lee, Suk-Joon Chang, Byung Su Kwon, et al.
Gynecologic Oncology|May 1, 2025
Oncologic outcomes of minimally invasive surgery vs. abdominal hysterectomy in patients with low-risk, early-stage cervical cancer: A retrospective analysis of KGOG 1028 data based on SHAPE trial eligibility criteriaJaekyung Bae, Uisuk Kim, E Sun Paik, et al.
Pageof 31